Trial Outcomes & Findings for Impact of Transcutaneous Vagal Nerve Stimulation on Stress Response in Major Depression (NCT NCT04448327)
NCT ID: NCT04448327
Last Updated: 2026-08-13
Results Overview
A functional magnetic resonance imaging (fMRI) analysis was used to evaluate changes in brain activity \[blood oxygenation level-dependent (BOLD) signal\] in response to a visual stress challenge during transcutaneous vagus nerve stimulation. For this analysis a General Lineal Model analysis with the statistical parametrical software (SPM) was used to model the change in BOLD signals during exposure to negative vs neutral images of the stress task. A voxel-wise height threshold of p\<0.001, and a cluster correction with FWE p-value \<0.05 was used to identify brain areas with significant activation in response to the task. Mean beta weights within each significant cluster were extracted for each participant, and average beta weights were estimated for each group. A positive value indicates increased activation of a particular brain region in response to the stress task during the stimulation, whereas a negative value indicates a reduction in brain activity.
COMPLETED
NA
62 participants
1 hour
2026-08-13
Participant Flow
Participant milestones
| Measure |
Active tVNS
Expiratory-gated transcutaneous vagus nerve stimulation on the left auricle
active tVNS: non-painful electrical stimulation of the auricle for 30 minutes during a functional magnetic resonance imaging session
|
Sham tVNS
Sham transcutaneous vagus nerve stimulation on the left auricle
Sham tVNS: Sham stimulation of the auricle for 30 minutes during a functional magnetic resonance imaging session
|
|---|---|---|
|
Overall Study
STARTED
|
34
|
28
|
|
Overall Study
COMPLETED
|
34
|
28
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Impact of Transcutaneous Vagal Nerve Stimulation on Stress Response in Major Depression
Baseline characteristics by cohort
| Measure |
Active tVNS
n=34 Participants
Expiratory-gated transcutaneous vagus nerve stimulation on the left auricle
active tVNS: non-painful electrical stimulation of the auricle for 30 minutes during a functional magnetic resonance imaging session
|
Sham tVNS
n=28 Participants
Sham transcutaneous vagus nerve stimulation on the left auricle
Sham tVNS: Sham stimulation of the auricle for 30 minutes during a functional magnetic resonance imaging session
|
Total
n=62 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
60 years
STANDARD_DEVIATION 1.7 • n=1 Participants
|
59 years
STANDARD_DEVIATION 1.8 • n=1 Participants
|
60 years
STANDARD_DEVIATION 1.8 • n=1 Participants
|
|
Sex: Female, Male
Female
|
24 Participants
n=1 Participants
|
17 Participants
n=1 Participants
|
41 Participants
n=1 Participants
|
|
Sex: Female, Male
Male
|
10 Participants
n=1 Participants
|
11 Participants
n=1 Participants
|
21 Participants
n=1 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=1 Participants
|
0 Participants
n=1 Participants
|
0 Participants
n=1 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=1 Participants
|
0 Participants
n=1 Participants
|
0 Participants
n=1 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
1 Participants
n=1 Participants
|
0 Participants
n=1 Participants
|
1 Participants
n=1 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=1 Participants
|
4 Participants
n=1 Participants
|
4 Participants
n=1 Participants
|
|
Race (NIH/OMB)
White
|
32 Participants
n=1 Participants
|
24 Participants
n=1 Participants
|
56 Participants
n=1 Participants
|
|
Race (NIH/OMB)
More than one race
|
1 Participants
n=1 Participants
|
0 Participants
n=1 Participants
|
1 Participants
n=1 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=1 Participants
|
0 Participants
n=1 Participants
|
0 Participants
n=1 Participants
|
|
Beck Depression Inventory score
|
5.9 units on a scale
STANDARD_DEVIATION 6.2 • n=1 Participants
|
8.1 units on a scale
STANDARD_DEVIATION 6.3 • n=1 Participants
|
6.9 units on a scale
STANDARD_DEVIATION 6.3 • n=1 Participants
|
PRIMARY outcome
Timeframe: 1 hourPopulation: Participants that completed fMRI scans in the study were included in the analysis.
A functional magnetic resonance imaging (fMRI) analysis was used to evaluate changes in brain activity \[blood oxygenation level-dependent (BOLD) signal\] in response to a visual stress challenge during transcutaneous vagus nerve stimulation. For this analysis a General Lineal Model analysis with the statistical parametrical software (SPM) was used to model the change in BOLD signals during exposure to negative vs neutral images of the stress task. A voxel-wise height threshold of p\<0.001, and a cluster correction with FWE p-value \<0.05 was used to identify brain areas with significant activation in response to the task. Mean beta weights within each significant cluster were extracted for each participant, and average beta weights were estimated for each group. A positive value indicates increased activation of a particular brain region in response to the stress task during the stimulation, whereas a negative value indicates a reduction in brain activity.
Outcome measures
| Measure |
Active tVNS
n=29 Participants
Expiratory-gated transcutaneous vagus nerve stimulation on the left auricle
active tVNS: non-painful electrical stimulation of the auricle for 30 minutes during a functional magnetic resonance imaging session
|
Sham tVNS
n=24 Participants
Sham transcutaneous vagus nerve stimulation on the left auricle
Sham tVNS: Sham stimulation of the auricle for 30 minutes during a functional magnetic resonance imaging session
|
|---|---|---|
|
Change in Brain Activity (Average Beta Weights From Significantly Activated Regions) Evaluated Using Functional Magnetic Resonance Imaging (fMRI)
Hyppocampus activity (Beta weight average in response to stress task)
|
0.28 Beta weight
Standard Deviation 0.34
|
0.03 Beta weight
Standard Deviation 0.31
|
|
Change in Brain Activity (Average Beta Weights From Significantly Activated Regions) Evaluated Using Functional Magnetic Resonance Imaging (fMRI)
Locus Coeruleus activity (Beta weight average in response to stress task)
|
0.27 Beta weight
Standard Deviation 0.47
|
0.01 Beta weight
Standard Deviation 0.40
|
PRIMARY outcome
Timeframe: 1 hourPopulation: Participants with HRV data were included in the final analysis. HRV data from five subjects in the active group and four in the sham group were excluded due to low-quality cardiac pulsatility signals.
Cardiac pulsatility data were collected during baseline and exposure to a visual stress task. Interbeat intervals were estimated, and a point-process algorithm was then used to evaluate heart rate variability dynamics in the classic spectral components within the high-frequency (HF) and low-frequency (LF) ranges. Normalized HF \[HFn=(HF/(LF+HF))\] values were estimated during exposure to the stress task as a metric of parasympathetic regulation. The percent change in HFn (during the stress task vs baseline) was calculated for each intervention group. A positive percent change value indicates an increase in cardiovagal activity, whereas a negative change indicates a reduction in cardiovagal activity.
Outcome measures
| Measure |
Active tVNS
n=29 Participants
Expiratory-gated transcutaneous vagus nerve stimulation on the left auricle
active tVNS: non-painful electrical stimulation of the auricle for 30 minutes during a functional magnetic resonance imaging session
|
Sham tVNS
n=25 Participants
Sham transcutaneous vagus nerve stimulation on the left auricle
Sham tVNS: Sham stimulation of the auricle for 30 minutes during a functional magnetic resonance imaging session
|
|---|---|---|
|
Percent Change in Normalized High Frequency Power - Heart Rate Variability From Baseline
|
3.25 Percent change in normalized HF-HRV
Standard Deviation 24.0
|
-7.2 Percent change in normalized HF-HRV
Standard Deviation 30.5
|
SECONDARY outcome
Timeframe: 2 hoursPopulation: Participants with cortisol response results were included in the analysis. Four participants in the active group and five participants in the sham group were excluded because of insufficient sample.
Changes in serum cortisol levels from baseline to post-stimulation will be assessed and compared between active and sham tVNS
Outcome measures
| Measure |
Active tVNS
n=30 Participants
Expiratory-gated transcutaneous vagus nerve stimulation on the left auricle
active tVNS: non-painful electrical stimulation of the auricle for 30 minutes during a functional magnetic resonance imaging session
|
Sham tVNS
n=23 Participants
Sham transcutaneous vagus nerve stimulation on the left auricle
Sham tVNS: Sham stimulation of the auricle for 30 minutes during a functional magnetic resonance imaging session
|
|---|---|---|
|
Change in Serum Cortisol Levels
|
-0.72 micrograms per deciliter
Standard Deviation 2.69
|
-1.33 micrograms per deciliter
Standard Deviation 2.76
|
SECONDARY outcome
Timeframe: 2 hoursPopulation: Participants with available proinflammatory cytokines responses were included in the analysis. Seven participants from the active group and 6 from the sham group were excluded due to insufficient samples.
Changes in serum levels of proinflammatory cytokines (IL1B, IL6, TNF alfa) from baseline to post-stimulation will be assessed and compared between active and sham tVNS
Outcome measures
| Measure |
Active tVNS
n=27 Participants
Expiratory-gated transcutaneous vagus nerve stimulation on the left auricle
active tVNS: non-painful electrical stimulation of the auricle for 30 minutes during a functional magnetic resonance imaging session
|
Sham tVNS
n=22 Participants
Sham transcutaneous vagus nerve stimulation on the left auricle
Sham tVNS: Sham stimulation of the auricle for 30 minutes during a functional magnetic resonance imaging session
|
|---|---|---|
|
Change in Serum Levels of Pro-inflammatory Cytokines
IL1B change
|
-0.43 pg/mL
Standard Deviation 0.41
|
-2.03 pg/mL
Standard Deviation 6.79
|
|
Change in Serum Levels of Pro-inflammatory Cytokines
IL6 change
|
3.23 pg/mL
Standard Deviation 4.85
|
1.11 pg/mL
Standard Deviation 8.81
|
|
Change in Serum Levels of Pro-inflammatory Cytokines
TNF alpha change
|
-5.50 pg/mL
Standard Deviation 4.40
|
-9.5 pg/mL
Standard Deviation 6.65
|
SECONDARY outcome
Timeframe: 2 hoursPopulation: Participants with available BDI data were included in the analysis
Changes from baseline to post-stimulation in the score of the Beck Depression Inventory will be compared between active and sham tVNS. (Beck depression inventory minimum score= 0, maximum score= 63; higher total scores indicate more severe depressive symptoms)
Outcome measures
| Measure |
Active tVNS
n=34 Participants
Expiratory-gated transcutaneous vagus nerve stimulation on the left auricle
active tVNS: non-painful electrical stimulation of the auricle for 30 minutes during a functional magnetic resonance imaging session
|
Sham tVNS
n=28 Participants
Sham transcutaneous vagus nerve stimulation on the left auricle
Sham tVNS: Sham stimulation of the auricle for 30 minutes during a functional magnetic resonance imaging session
|
|---|---|---|
|
Change in Depressive Symptoms Assessed by the Beck Depression Inventory
|
-0.58 Differences in BDI scale score
Standard Deviation 2.13
|
-1.0 Differences in BDI scale score
Standard Deviation 2.43
|
Adverse Events
Active tVNS
Sham tVNS
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Active tVNS
n=34 participants at risk
Expiratory-gated transcutaneous vagus nerve stimulation on the left auricle
active tVNS: non-painful electrical stimulation of the auricle for 30 minutes during a functional magnetic resonance imaging session
|
Sham tVNS
n=28 participants at risk
Sham transcutaneous vagus nerve stimulation on the left auricle
Sham tVNS: Sham stimulation of the auricle for 30 minutes during a functional magnetic resonance imaging session
|
|---|---|---|
|
General disorders
Headache
|
8.8%
3/34 • Number of events 3 • 1 day
|
3.6%
1/28 • Number of events 1 • 1 day
|
|
General disorders
Light-headedness
|
0.00%
0/34 • 1 day
|
3.6%
1/28 • Number of events 1 • 1 day
|
|
General disorders
Anxiety
|
2.9%
1/34 • Number of events 1 • 1 day
|
3.6%
1/28 • Number of events 1 • 1 day
|
|
Skin and subcutaneous tissue disorders
Soreness in ear
|
2.9%
1/34 • Number of events 1 • 1 day
|
0.00%
0/28 • 1 day
|
|
Gastrointestinal disorders
Nausea
|
0.00%
0/34 • 1 day
|
3.6%
1/28 • Number of events 1 • 1 day
|
Additional Information
Ronald G. Garcia
Massachusetts General Hospital, Harvard Medical School
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place